JP2009247889A - 繋留縫合糸 - Google Patents
繋留縫合糸 Download PDFInfo
- Publication number
- JP2009247889A JP2009247889A JP2009058588A JP2009058588A JP2009247889A JP 2009247889 A JP2009247889 A JP 2009247889A JP 2009058588 A JP2009058588 A JP 2009058588A JP 2009058588 A JP2009058588 A JP 2009058588A JP 2009247889 A JP2009247889 A JP 2009247889A
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- loop
- anchors
- suture
- elongate body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004873 anchoring Methods 0.000 title description 40
- 230000007704 transition Effects 0.000 claims abstract description 19
- 210000001519 tissue Anatomy 0.000 claims description 48
- -1 gut Polymers 0.000 claims description 36
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 16
- 229920001577 copolymer Polymers 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000004743 Polypropylene Substances 0.000 claims description 10
- 229920001155 polypropylene Polymers 0.000 claims description 10
- 230000002745 absorbent Effects 0.000 claims description 9
- 239000002250 absorbent Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- 238000005520 cutting process Methods 0.000 claims description 8
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 8
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 8
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical group CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 7
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 7
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 239000003292 glue Substances 0.000 claims description 6
- 238000000465 moulding Methods 0.000 claims description 6
- 210000004872 soft tissue Anatomy 0.000 claims description 6
- 238000003466 welding Methods 0.000 claims description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 238000012377 drug delivery Methods 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- SJDLIJNQXLJBBE-UHFFFAOYSA-N 1,4-dioxepan-2-one Chemical compound O=C1COCCCO1 SJDLIJNQXLJBBE-UHFFFAOYSA-N 0.000 claims description 4
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 4
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 claims description 4
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 4
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 4
- 230000003872 anastomosis Effects 0.000 claims description 4
- 230000003416 augmentation Effects 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920001971 elastomer Polymers 0.000 claims description 4
- 229920001778 nylon Polymers 0.000 claims description 4
- 239000005060 rubber Substances 0.000 claims description 4
- 230000017423 tissue regeneration Effects 0.000 claims description 4
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 4
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 3
- 239000000565 sealant Substances 0.000 claims description 3
- 239000002407 tissue scaffold Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 description 28
- 238000000034 method Methods 0.000 description 20
- 239000000835 fiber Substances 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 239000000203 mixture Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229940001447 lactate Drugs 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- 239000004952 Polyamide Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 238000009954 braiding Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 229920001651 Cyanoacrylate Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003429 antifungal agent Substances 0.000 description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 3
- 229940127089 cytotoxic agent Drugs 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000009740 moulding (composite fabrication) Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- AOLNDUQWRUPYGE-UHFFFAOYSA-N 1,4-dioxepan-5-one Chemical compound O=C1CCOCCO1 AOLNDUQWRUPYGE-UHFFFAOYSA-N 0.000 description 2
- FMHKPLXYWVCLME-UHFFFAOYSA-N 4-hydroxy-valeric acid Chemical compound CC(O)CCC(O)=O FMHKPLXYWVCLME-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000431 shape-memory polymer Polymers 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- ICGQLNMKJVHCIR-UHFFFAOYSA-N 1,3,2-dioxazetidin-4-one Chemical compound O=C1ONO1 ICGQLNMKJVHCIR-UHFFFAOYSA-N 0.000 description 1
- VKSWWACDZPRJAP-UHFFFAOYSA-N 1,3-dioxepan-2-one Chemical compound O=C1OCCCCO1 VKSWWACDZPRJAP-UHFFFAOYSA-N 0.000 description 1
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 description 1
- PFSVSOOFNDBGMO-UHFFFAOYSA-N 3-methoxypropyl 2-cyanoprop-2-enoate Chemical compound COCCCOC(=O)C(=C)C#N PFSVSOOFNDBGMO-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- PQWFTDJAVBWVRA-UHFFFAOYSA-L C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCC)[Al+2].C(C(O)C)(=O)[O-] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCC)[Al+2].C(C(O)C)(=O)[O-] PQWFTDJAVBWVRA-UHFFFAOYSA-L 0.000 description 1
- OIKFXRCDUQOYBG-UHFFFAOYSA-M C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCC)[Ca+] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCC)[Ca+] OIKFXRCDUQOYBG-UHFFFAOYSA-M 0.000 description 1
- PAHUANPRNXUUHU-UHFFFAOYSA-M C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCC)[Mg+] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCC)[Mg+] PAHUANPRNXUUHU-UHFFFAOYSA-M 0.000 description 1
- JKZWWLBUMWZFOF-UHFFFAOYSA-L C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Al+2].C(C(O)C)(=O)[O-] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Al+2].C(C(O)C)(=O)[O-] JKZWWLBUMWZFOF-UHFFFAOYSA-L 0.000 description 1
- GFDMDZIJTBJKNB-UHFFFAOYSA-M C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Ba+] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Ba+] GFDMDZIJTBJKNB-UHFFFAOYSA-M 0.000 description 1
- FDKAAIFOPLCYAM-UHFFFAOYSA-M C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Ca+] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Ca+] FDKAAIFOPLCYAM-UHFFFAOYSA-M 0.000 description 1
- IIHFEWVUKSUHFU-UHFFFAOYSA-M C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Mg+] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Mg+] IIHFEWVUKSUHFU-UHFFFAOYSA-M 0.000 description 1
- OWKBRQGNBWICPH-UHFFFAOYSA-M C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Zn+] Chemical compound C(C(O)C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[Zn+] OWKBRQGNBWICPH-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
- 101710127797 Macrophage colony-stimulating factor 1 Proteins 0.000 description 1
- 102000013967 Monokines Human genes 0.000 description 1
- 108010050619 Monokines Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Chemical class 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000003916 calcium stearoyl-2-lactylate Substances 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 1
- 229950010048 enbucrilate Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 229940053009 ethyl cyanoacrylate Drugs 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000002241 furanones Chemical class 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- QRWOVIRDHQJFDB-UHFFFAOYSA-N isobutyl cyanoacrylate Chemical compound CC(C)COC(=O)C(=C)C#N QRWOVIRDHQJFDB-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- RPQUGMLCZLGZTG-UHFFFAOYSA-N octyl cyanoacrylate Chemical compound CCCCCCCCOC(=O)C(=C)C#N RPQUGMLCZLGZTG-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920006260 polyaryletherketone Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920000570 polyether Chemical class 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940076376 protein agonist Drugs 0.000 description 1
- 229940076372 protein antagonist Drugs 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00792—Plastic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06004—Means for attaching suture to needle
- A61B2017/06028—Means for attaching suture to needle by means of a cylindrical longitudinal blind bore machined at the suture-receiving end of the needle, e.g. opposite to needle tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
- A61B2017/06176—Sutures with protrusions, e.g. barbs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
Abstract
【解決手段】医療デバイスであって、近位部分および遠位部分を有する細長本体10を備え、該細長本体の該近位部分は、自由端11で終わり;該細長本体の該遠位部分は、ループ14で終わり;そして該ループは、該ループの表面に沿って配置された第一の複数のアンカー18を備える、医療デバイス。上記第一の複数のアンカーは、上記細長本体と上記ループとの交差部によって規定されている移行領域に隣接し得る。
【選択図】図3
Description
本願は、2008年4月1日に出願された、米国仮特許出願番号61/041,302の利益および優先権を主張する。この米国仮特許出願の全開示は、本明細書中に参考として援用される。
本開示は、一般に、外科手術用デバイスの分野に関し、そしてより特定すると、表面に沿って配置されたアンカーを有する遠位ループを備える縫合糸などのデバイスに関する。
外科手術用縫合糸は、種々の型の医療手順(組織および創傷の閉鎖が挙げられる)のために首尾よく使用されている。外科手術用縫合糸は、代表的に、一端に取り付けられた針を有する。この針が組織に貫入すると、この縫合糸が組織に入り、この組織を通過し、そしてこの組織を出、この地点で、組織または創傷を固定するために、結び目が使用され得る。
(項目1)
医療デバイスであって、
近位部分および遠位部分を有する細長本体
を備え、
該細長本体の該近位部分は、自由端で終わり;
該細長本体の該遠位部分は、ループで終わり;そして
該ループは、該ループの表面に沿って配置された第一の複数のアンカーを備える、
医療デバイス。
医療デバイスであって、
近位部分および遠位部分を有する細長本体
を備え、
該細長本体の該近位部分は、自由端を有し;
該細長本体の該遠位部分は、ループに移行し;そして
該ループは、第一の複数の組織係合部材を備え、該第一の複数の組織係合部材は、該細長本体に隣接している、
医療デバイス。
上記第一の複数のアンカーが移行領域に隣接しており、該移行領域が、上記細長本体と上記ループとの交差部によって規定されている、項目1に記載の医療デバイス。
上記第一の複数のアンカーが、組織を通る上記ループの動きを制限する、項目1または2に記載の医療デバイス。
上記ループが、超音波エネルギー、溶接、切削、接着、または成形によって形成される、項目1または2に記載の医療デバイス。
上記ループが、超音波エネルギーにより形成され、そして上記近位部分が、第二の複数のアンカーを有し、該第一の複数のアンカーは、第一の方向に延び、そして該第二の複数のアンカーは、第二の方向に延び、該第二の方向は、該第一の方向とは異なる、項目5に記載の医療デバイス。
上記ループが、接着剤、膠、または封止剤の使用によって作製される、項目5に記載の医療デバイス。
上記近位部分に取り付けられた針をさらに備え織る、項目1または2に記載の医療デバイス。
上記医療デバイスが、縫合糸、クリップ、ファスナー、包帯、帯具、メッシュ、薬物送達デバイス、吻合リング、ステント、移植片、カテーテルシステム、組織足場、バットレス、軟部組織修復および増強デバイス、綿撒糸、ラップバンド、テープ、およびリボンからなる群より選択される、項目1または2に記載の医療デバイス。
上記医療デバイスが縫合糸である、項目9に記載の医療デバイス。
上記医療デバイスが、吸収性、非吸収性、またはこれらの組み合わせである、項目1または2に記載の医療デバイス。
上記医療デバイスが、ラクチド、グリコリド、カプロラクトン、バレロラクトン、トリメチレンカーボネート、1,4−ジオキサノン、δ−バレロラクトン、ε−カプロラクトン、1,4−ジオキセパン−2−オン、1,5−ジオキセパン−2−オン、コラーゲン、ガット、ポリマー薬物、エチレングリコール、エチレンオキシド、エステルアミド、γ−ヒドロキシバレレート、β−ヒドロキシプロピオネート、α−ヒドロキシ酸、およびβ−ヒドロキシブチレート、コラーゲン、セルロース、ガット、ならびにこれらのコポリマーからなる群より選択される吸収性ポリマーを含む、項目11に記載の医療デバイス。
上記医療デバイスが、絹、綿、ゴム、ナイロン、ポリプロピレン、ポリエチレン、超高分子量ポリエチレン(UHMWPE)、ポリエチレンテレフタレート(PET)、およびポリエステル、ならびにこれらのコポリマーからなる群より選択される非吸収性ポリマーを含む、項目11に記載の医療デバイス。
医療薬剤をさらに含む、項目1または2に記載の医療デバイス。
上記細長本体が、第二の複数の組織係合部材をさらに備える、項目1または2に記載の医療デバイス。
上記第一の複数のアンカーが、上記第二の複数のアンカーとは異なる、項目15に記載の医療デバイス。
上記第一の複数のアンカーおよび上記第二の複数のアンカーのうちのいずれかまたは両方のうちの、1つ以上のアンカーが、少なくとも1つの複合棘を規定する、項目15に記載の医療デバイス。
上記複合棘が、第一の部分および第二の部分を有する内側表面を規定し、該第一の部分が、上記細長本体の長手方向軸に対する第一の配向を含み、該第二の部分が、該長手方向軸に対する第二の配向で配置され、そして必要に応じて、第三の部分が、該長手方向軸に対して第三の配向で配置されており、該第一の配向と、第二の配向と、第三の配向とが異なる、項目17に記載の医療デバイス。
本開示は、医療デバイスに関し、この医療デバイスは、近位部分および遠位部分を有する細長本体を有し、この近位部分は、自由端で終わり、そしてこの遠位部分は、ループで終わる。このループはまた、このループの表面に沿って配置された、第一の複数のアンカーを備える。この細長本体はまた、第二の複数のアンカーを備え得、ここで第一の複数のアンカーは、第二の複数のアンカーとは異なる。好ましい実施形態において、第一の複数のアンカーは、移行領域に隣接して配置される。この移行領域は、この細長本体とこのループとの交差部によって規定される。本明細書中に記載されるように、第一の複数のアンカーは、組織を通るループの動きを制限し得る。
本開示は、医療デバイスに関し、そして好ましい実施形態において、縫合糸に関し、この縫合糸は、本明細書中で、繋留縫合糸と称される。開示される繋留縫合糸は、細長本体を有し、この細長本体は、近位端において針に接続され、そしてこの細長本体の遠位端は、繋留ループまで延びる。この繋留ループは、複数のアンカー(組織係合部材)をさらに備える。本開示の医療デバイスは、繊維、フィラメント、および糸から形成された縫合糸を備える。
MaxonTM縫合糸の遠位端を、細長本体の方に折り畳んでループを形成し、次いで、縫合糸(ループ)を超音波溶接装置に入れ、この装置の中で、このループを溶接により閉じる。次いで、縫合糸を超音波切削装置に固定して、棘を作製する。繋留縫合糸の細長本体および繋留ループを、超音波刃によって種々の角度で切り出す。
SurgiproTM縫合糸の遠位端を細長本体の方に折り畳んでループを作製し、そして膠を、この細長本体に配置し、そして縫合糸の遠位端を細長本体上に折り畳んでこの細長本体に取り付け、固定されたループを作製する。次いで、縫合糸を切削装置に取り付け、そして繋留縫合糸を種々の角度で、ナイフを使用して切り出す。次いで、繋留縫合糸を、溶媒キャスティングを使用して、化学療法剤でコーティングする。
10 細長本体
11 自由端
12 針
14 ループ
14a、14b 枝
16 移行領域
18 アンカー
Claims (18)
- 医療デバイスであって、
近位部分および遠位部分を有する細長本体
を備え、
該細長本体の該近位部分は、自由端で終わり;
該細長本体の該遠位部分は、ループで終わり;そして
該ループは、該ループの表面に沿って配置された第一の複数のアンカーを備える、
医療デバイス。 - 医療デバイスであって、
近位部分および遠位部分を有する細長本体
を備え、
該細長本体の該近位部分は、自由端を有し;
該細長本体の該遠位部分は、ループに移行し;そして
該ループは、第一の複数の組織係合部材を備え、該第一の複数の組織係合部材は、該細長本体に隣接している、
医療デバイス。 - 前記第一の複数のアンカーが移行領域に隣接しており、該移行領域が、前記細長本体と前記ループとの交差部によって規定されている、請求項1に記載の医療デバイス。
- 前記第一の複数のアンカーが、組織を通る前記ループの動きを制限する、請求項1または2に記載の医療デバイス。
- 前記ループが、超音波エネルギー、溶接、切削、接着、または成形によって形成される、請求項1または2に記載の医療デバイス。
- 前記ループが、超音波エネルギーにより形成され、そして前記近位部分が、第二の複数のアンカーを有し、該第一の複数のアンカーは、第一の方向に延び、そして該第二の複数のアンカーは、第二の方向に延び、該第二の方向は、該第一の方向とは異なる、請求項5に記載の医療デバイス。
- 前記ループが、接着剤、膠、または封止剤の使用によって作製される、請求項5に記載の医療デバイス。
- 前記近位部分に取り付けられた針をさらに備え織る、請求項1または2に記載の医療デバイス。
- 前記医療デバイスが、縫合糸、クリップ、ファスナー、包帯、帯具、メッシュ、薬物送達デバイス、吻合リング、ステント、移植片、カテーテルシステム、組織足場、バットレス、軟部組織修復および増強デバイス、綿撒糸、ラップバンド、テープ、およびリボンからなる群より選択される、請求項1または2に記載の医療デバイス。
- 前記医療デバイスが縫合糸である、請求項9に記載の医療デバイス。
- 前記医療デバイスが、吸収性、非吸収性、またはこれらの組み合わせである、請求項1または2に記載の医療デバイス。
- 前記医療デバイスが、ラクチド、グリコリド、カプロラクトン、バレロラクトン、トリメチレンカーボネート、1,4−ジオキサノン、δ−バレロラクトン、ε−カプロラクトン、1,4−ジオキセパン−2−オン、1,5−ジオキセパン−2−オン、コラーゲン、ガット、ポリマー薬物、エチレングリコール、エチレンオキシド、エステルアミド、γ−ヒドロキシバレレート、β−ヒドロキシプロピオネート、α−ヒドロキシ酸、およびβ−ヒドロキシブチレート、コラーゲン、セルロース、ガット、ならびにこれらのコポリマーからなる群より選択される吸収性ポリマーを含む、請求項11に記載の医療デバイス。
- 前記医療デバイスが、絹、綿、ゴム、ナイロン、ポリプロピレン、ポリエチレン、超高分子量ポリエチレン(UHMWPE)、ポリエチレンテレフタレート(PET)、およびポリエステル、ならびにこれらのコポリマーからなる群より選択される非吸収性ポリマーを含む、請求項11に記載の医療デバイス。
- 医療薬剤をさらに含む、請求項1または2に記載の医療デバイス。
- 前記細長本体が、第二の複数の組織係合部材をさらに備える、請求項1または2に記載の医療デバイス。
- 前記第一の複数のアンカーが、前記第二の複数のアンカーとは異なる、請求項15に記載の医療デバイス。
- 前記第一の複数のアンカーおよび前記第二の複数のアンカーのうちのいずれかまたは両方のうちの、1つ以上のアンカーが、少なくとも1つの複合棘を規定する、請求項15に記載の医療デバイス。
- 前記複合棘が、第一の部分および第二の部分を有する内側表面を規定し、該第一の部分が、前記細長本体の長手方向軸に対する第一の配向を含み、該第二の部分が、該長手方向軸に対する第二の配向で配置され、そして必要に応じて、第三の部分が、該長手方向軸に対して第三の配向で配置されており、該第一の配向と、第二の配向と、第三の配向とが異なる、請求項17に記載の医療デバイス。
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4130208P | 2008-04-01 | 2008-04-01 | |
| US61/041,302 | 2008-04-01 | ||
| US12/362,002 | 2009-01-29 | ||
| US12/362,002 US10376261B2 (en) | 2008-04-01 | 2009-01-29 | Anchoring suture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009247889A true JP2009247889A (ja) | 2009-10-29 |
| JP5570045B2 JP5570045B2 (ja) | 2014-08-13 |
Family
ID=40637088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009058588A Expired - Fee Related JP5570045B2 (ja) | 2008-04-01 | 2009-03-11 | 繋留縫合糸 |
| JP2009079732A Expired - Fee Related JP5570046B2 (ja) | 2008-04-01 | 2009-03-27 | 係留デバイス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009079732A Expired - Fee Related JP5570046B2 (ja) | 2008-04-01 | 2009-03-27 | 係留デバイス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10376261B2 (ja) |
| EP (3) | EP2106752B1 (ja) |
| JP (2) | JP5570045B2 (ja) |
| AU (1) | AU2009200741B2 (ja) |
| CA (2) | CA2655779A1 (ja) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011019902A (ja) * | 2009-07-17 | 2011-02-03 | Tyco Healthcare Group Lp | 医療デバイスをコーティングする方法 |
| JP2011189131A (ja) * | 2010-03-12 | 2011-09-29 | Tyco Healthcare Group Lp | 外科手術用縫合糸のための展開システム |
| JP2011194234A (ja) * | 2010-03-19 | 2011-10-06 | Tyco Healthcare Group Lp | 先端がテーパー状にされたループ付き縫合糸 |
| JP2011240133A (ja) * | 2010-05-20 | 2011-12-01 | Tyco Healthcare Group Lp | 繋留デバイス |
| JP2013511322A (ja) * | 2010-06-09 | 2013-04-04 | メタ バイオメド カンパニー リミテッド | 手術用縫合糸の製造方法 |
| JP2013531533A (ja) * | 2010-07-08 | 2013-08-08 | アシュット ヨーロップ エス.ピー.エー. | 縫合糸 |
| WO2013168932A1 (ko) * | 2012-05-07 | 2013-11-14 | Jeong Chang Wook | 결찰 장치 |
| JP2014516605A (ja) * | 2011-03-23 | 2014-07-17 | エシコン・エルエルシー | 自己保持可変ループ縫合材 |
| US9498893B2 (en) | 2007-09-27 | 2016-11-22 | Ethicon, Inc. | Self-retaining sutures including tissue retainers having improved strength |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8795332B2 (en) | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
| US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
| US5931855A (en) | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
| US7056331B2 (en) | 2001-06-29 | 2006-06-06 | Quill Medical, Inc. | Suture method |
| US6848152B2 (en) | 2001-08-31 | 2005-02-01 | Quill Medical, Inc. | Method of forming barbs on a suture and apparatus for performing same |
| US6773450B2 (en) | 2002-08-09 | 2004-08-10 | Quill Medical, Inc. | Suture anchor and method |
| US8100940B2 (en) | 2002-09-30 | 2012-01-24 | Quill Medical, Inc. | Barb configurations for barbed sutures |
| US20040088003A1 (en) | 2002-09-30 | 2004-05-06 | Leung Jeffrey C. | Barbed suture in combination with surgical needle |
| US7624487B2 (en) | 2003-05-13 | 2009-12-01 | Quill Medical, Inc. | Apparatus and method for forming barbs on a suture |
| WO2005112787A2 (en) | 2004-05-14 | 2005-12-01 | Quill Medical, Inc. | Suture methods and devices |
| US8821542B2 (en) | 2006-10-31 | 2014-09-02 | Depuy Mitek, Llc | Suture management system |
| US8915943B2 (en) | 2007-04-13 | 2014-12-23 | Ethicon, Inc. | Self-retaining systems for surgical procedures |
| EP2222233B1 (en) | 2007-12-19 | 2020-03-25 | Ethicon, LLC | Self-retaining sutures with heat-contact mediated retainers |
| US8916077B1 (en) | 2007-12-19 | 2014-12-23 | Ethicon, Inc. | Self-retaining sutures with retainers formed from molten material |
| US8118834B1 (en) | 2007-12-20 | 2012-02-21 | Angiotech Pharmaceuticals, Inc. | Composite self-retaining sutures and method |
| US8615856B1 (en) | 2008-01-30 | 2013-12-31 | Ethicon, Inc. | Apparatus and method for forming self-retaining sutures |
| US8875607B2 (en) | 2008-01-30 | 2014-11-04 | Ethicon, Inc. | Apparatus and method for forming self-retaining sutures |
| US8273105B2 (en) | 2008-02-20 | 2012-09-25 | Tyco Healthcare Group Lp | Compound barb medical device and method |
| US8888810B2 (en) | 2008-02-20 | 2014-11-18 | Covidien Lp | Compound barb medical device and method |
| EP3533399A3 (en) | 2008-02-21 | 2019-10-23 | Ethicon LLC | Method for elevating retainers on self-retaining sutures |
| US8216273B1 (en) | 2008-02-25 | 2012-07-10 | Ethicon, Inc. | Self-retainers with supporting structures on a suture |
| US8641732B1 (en) | 2008-02-26 | 2014-02-04 | Ethicon, Inc. | Self-retaining suture with variable dimension filament and method |
| US9358002B2 (en) | 2008-04-01 | 2016-06-07 | Covidien Lp | Anchoring device |
| US8932327B2 (en) | 2008-04-01 | 2015-01-13 | Covidien Lp | Anchoring device |
| US10376261B2 (en) * | 2008-04-01 | 2019-08-13 | Covidien Lp | Anchoring suture |
| CN102056552B (zh) | 2008-04-15 | 2013-07-03 | 伊西康有限责任公司 | 具有双向保持器或单向保持器的自保持缝合线 |
| US8961560B2 (en) | 2008-05-16 | 2015-02-24 | Ethicon, Inc. | Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods |
| US10016196B2 (en) | 2008-09-11 | 2018-07-10 | Covidien Lp | Tapered looped suture |
| US8056599B2 (en) * | 2008-09-24 | 2011-11-15 | Tyco Healthcare Group Lp | System and method of making tapered looped suture |
| US8403017B2 (en) * | 2008-10-27 | 2013-03-26 | Covidien Lp | System, method and apparatus for making tapered looped suture |
| MX381532B (es) | 2008-11-03 | 2025-03-12 | Ethicon Llc | Longitud de sutura autorretenible y metodo y dispositivo para su uso. |
| US8590588B2 (en) * | 2009-04-29 | 2013-11-26 | Covidien Lp | System and method for making tapered looped suture |
| US9038688B2 (en) | 2009-04-29 | 2015-05-26 | Covidien Lp | System and method for making tapered looped suture |
| FI20096285L (fi) * | 2009-12-04 | 2011-06-05 | Conmed Linvatec Biomaterials Oy Ltd | Lämpömuovausmenetelmä ja menetelmän avulla saatavat tuotteet |
| ES2785076T3 (es) | 2010-03-26 | 2020-10-05 | Tepha Inc | Recubrimientos para la fabricación y la aplicación de dispositivos médicos de polihidroxialcanoato |
| WO2011126765A2 (en) | 2010-03-28 | 2011-10-13 | Frank Joshua B | Soft tissue fixation using a looped suture construct |
| US8398680B2 (en) | 2010-04-07 | 2013-03-19 | Lsi Solutions, Inc. | Bioabsorbable magnesium knots for securing surgical suture |
| US8968362B2 (en) | 2010-04-08 | 2015-03-03 | Covidien Lp | Coated looped suture |
| CN103096816B (zh) | 2010-05-04 | 2016-10-12 | 伊西康有限责任公司 | 用于产生自固位缝线的激光切割系统和方法 |
| EP3155978B1 (en) | 2010-06-11 | 2022-04-13 | Cilag GmbH International | Suture delivery tools for endoscopic and robot-assisted surgery |
| CA2806676A1 (en) * | 2010-07-28 | 2012-02-02 | Teleflex Medical Incorporated | Coated colored medical devices |
| US20120083838A1 (en) | 2010-10-01 | 2012-04-05 | Tyco Healthcare Group Lp | Connectable End Effector |
| US8398679B2 (en) | 2010-10-28 | 2013-03-19 | Covidien Lp | Modular suture |
| RU2608237C2 (ru) | 2010-11-03 | 2017-01-17 | ЭТИКОН ЭлЭлСи | Самоудерживающиеся шовные материалы, выделяющие лекарственные средства, и относящиеся к ним методы |
| BR112013011582B1 (pt) | 2010-11-09 | 2020-10-20 | Ethicon Llc | sistema de autorretenção multidirecional removível |
| JP6166662B2 (ja) * | 2010-12-23 | 2017-07-19 | サージマティクス,インコーポレーテッド | 回転針を用いた皮膚縫合装置 |
| KR101132841B1 (ko) | 2011-03-07 | 2012-04-02 | 김영재 | 봉합사 |
| EP2685940A4 (en) * | 2011-03-14 | 2015-01-21 | Topsfield Medical Gmbh | IMPLANTABLE GLENOID PROTESTS |
| US20120253388A1 (en) * | 2011-03-29 | 2012-10-04 | Tyco Healthcare Group Lp | Anchor Member For Looped Sutures |
| US20130172931A1 (en) | 2011-06-06 | 2013-07-04 | Jeffrey M. Gross | Methods and devices for soft palate tissue elevation procedures |
| US10973513B2 (en) | 2011-09-29 | 2021-04-13 | Ethicon, Llc | Barbed suture having increased holding strength |
| KR101185583B1 (ko) | 2011-12-27 | 2012-09-24 | 김영재 | 매듭짓는 작업이 필요 없는 봉합사 및 이를 포함하는 키트 |
| US20130204296A1 (en) * | 2012-02-06 | 2013-08-08 | Daniel Brauman | Absorbable Suture Device |
| US20130231699A1 (en) * | 2012-02-20 | 2013-09-05 | Dr7 Innovations, Llc | Locking suture |
| WO2014031578A1 (en) * | 2012-08-22 | 2014-02-27 | Covidien Lp | Tissue fixation device |
| US11672529B2 (en) | 2012-09-17 | 2023-06-13 | Cilag Gmbh International | Barbed sutures having contoured barbs that facilitate passage through tissue and increase holding strength |
| US10178990B2 (en) | 2012-12-05 | 2019-01-15 | Y. Jacobs Medical Inc. | Apparatus for inserting surgical thread, and surgical procedure kit for inserting surgical thread comprising same |
| US10010317B2 (en) | 2012-12-05 | 2018-07-03 | Young Jae Kim | Method of improving elasticity of tissue of living body |
| JP6145580B2 (ja) | 2013-12-06 | 2017-06-14 | ワイ.ジェイコブス メディカル インコーポレーテッド | 医療用管挿入装置およびこれを備える医療用管挿入施術キット |
| US9795378B2 (en) | 2014-10-31 | 2017-10-24 | Ethicon, Inc. | Method for approximating wounds |
| EP3085820B1 (en) | 2015-04-22 | 2017-12-20 | Sofradim Production | A method for forming a barbed suture and the barbed suture thus obtained |
| EP3085332B1 (en) | 2015-04-23 | 2019-02-27 | Sofradim Production | Package for a surgical mesh |
| US10188379B2 (en) | 2015-09-03 | 2019-01-29 | Ethicon Llc | End effector for wound closure device |
| US10336001B2 (en) | 2015-09-04 | 2019-07-02 | Ethicon, Inc. | End effector for wound closure device |
| USD780918S1 (en) | 2015-09-04 | 2017-03-07 | Ethicon, Inc. | Welded end effector |
| US10772986B2 (en) * | 2017-01-26 | 2020-09-15 | Allosource | Fascia fibrous compositions and methods for their use and manufacture |
| CA3079532A1 (en) | 2017-10-19 | 2019-04-25 | C.R.Bard, Inc. | Self-gripping hernia prosthesis |
| EP3476304B1 (en) * | 2017-10-26 | 2023-12-06 | Smith & Nephew, Inc. | Suture/needle constructs |
| EP3854316B1 (en) * | 2018-09-17 | 2024-04-24 | Labnpeople Co.,Ltd. | Thread embedding therapy rope and thread embedding therapy needle apparatus comprising same |
| US20220273297A1 (en) * | 2019-07-30 | 2022-09-01 | Chandrashekar BALACHANDRAN | Surgical Suture |
| US12349893B2 (en) | 2021-02-25 | 2025-07-08 | Cook Medical Technologies Llc | Implantable tissue anchors, kits that include a tissue anchor, and related methods of treatment |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4950285A (en) * | 1989-11-27 | 1990-08-21 | Wilk Peter J | Suture device |
| JPH04307052A (ja) * | 1991-01-07 | 1992-10-29 | United States Surgical Corp | ループ状糸付き外科用針−縫合糸組み合わせ装置 |
| JPH11502432A (ja) * | 1995-01-25 | 1999-03-02 | ユーン,インバエ | 組織の縫合方法および縫合装置 |
| JP2002511300A (ja) * | 1998-04-16 | 2002-04-16 | アクシーア メディカル インコーポレイテッド | 軟組織固定デバイス |
| JP2002224485A (ja) * | 2001-02-01 | 2002-08-13 | Bankoku Needle Mfg Co Ltd | ル−プ糸付き針 |
| JP2003512863A (ja) * | 1999-04-09 | 2003-04-08 | ジョゼフ カブコバ、ジョサファット | 組織の縫合方法及び装置 |
| US20050267531A1 (en) * | 2004-05-14 | 2005-12-01 | Ruff Gregory L | Suture methods and devices |
| US20060116718A1 (en) * | 2003-08-07 | 2006-06-01 | Leiboff Arnold R | Device and method for tacking a prosthetic screen |
| US20070224237A1 (en) * | 2006-03-24 | 2007-09-27 | Julia Hwang | Barbed sutures having a therapeutic agent thereon |
| WO2007133103A1 (en) * | 2006-05-16 | 2007-11-22 | Marlen Andreevich Sulamanidze | Surgical suture material and a method to the use thereof |
| US20080281357A1 (en) * | 2007-05-09 | 2008-11-13 | An-Min Jason Sung | Looped tissue-grasping device |
Family Cites Families (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123077A (en) * | 1964-03-03 | Surgical suture | ||
| US3657056A (en) * | 1967-12-11 | 1972-04-18 | Ultrasonic Systems | Ultrasonic suturing apparatus |
| US3922455A (en) * | 1972-05-23 | 1975-11-25 | Ingrip Fasteners | Linear element with grafted nibs and method therefor |
| US4024871A (en) * | 1975-07-23 | 1977-05-24 | Ethicon, Inc. | Antimicrobial sutures |
| US5019093A (en) * | 1989-04-28 | 1991-05-28 | United States Surgical Corporation | Braided suture |
| US5261886A (en) * | 1987-08-26 | 1993-11-16 | United States Surgical Corporation | Cabled core and braided suture made therefrom |
| US5226912A (en) * | 1987-08-26 | 1993-07-13 | United States Surgical Corporation | Combined surgical needle-braided suture device |
| US5306289A (en) * | 1987-08-26 | 1994-04-26 | United States Surgical Corporation | Braided suture of improved characteristics |
| US5002562A (en) * | 1988-06-03 | 1991-03-26 | Oberlander Michael A | Surgical clip |
| US5133738A (en) * | 1989-09-27 | 1992-07-28 | United States Surgical Corporation | Combined surgical needle-spiroid braided suture device |
| US5123913A (en) | 1989-11-27 | 1992-06-23 | Wilk Peter J | Suture device |
| US5059213A (en) * | 1990-03-26 | 1991-10-22 | United States Surgical Corporation | Spiroid braided suture |
| US5181923A (en) * | 1990-03-26 | 1993-01-26 | United States Surgical Corporation | Spiroid braided suture |
| US5236563A (en) * | 1990-06-18 | 1993-08-17 | Advanced Surface Technology Inc. | Surface-modified bioabsorbables |
| US5370031A (en) * | 1990-08-17 | 1994-12-06 | United States Surgical Corporation | Braider apparatus with improved bobbin holder |
| CA2048464A1 (en) * | 1990-08-17 | 1992-02-18 | Michael P. Chesterfield | Apparatus and method for producing braided suture products |
| CA2704219C (en) * | 1990-12-13 | 2011-01-04 | United States Surgical Corporation | Method and apparatus for tipping sutures |
| CA2059245C (en) | 1991-02-08 | 2004-07-06 | Michael P. Chesterfield | Method and apparatus for calendering and coating/filling sutures |
| US5269783A (en) * | 1991-05-13 | 1993-12-14 | United States Surgical Corporation | Device and method for repairing torn tissue |
| US5318575A (en) * | 1992-02-03 | 1994-06-07 | United States Surgical Corporation | Method of using a surgical repair suture product |
| US5417700A (en) * | 1992-03-30 | 1995-05-23 | Thomas D. Egan | Automatic suturing and ligating device |
| US5383883A (en) * | 1992-06-07 | 1995-01-24 | Wilk; Peter J. | Method for ultrasonically applying a surgical device |
| US5403346A (en) * | 1992-12-31 | 1995-04-04 | Loeser; Edward A. | Self-affixing suture assembly |
| US5312436A (en) * | 1993-03-11 | 1994-05-17 | Coffey William R | Suture for use in endoscopic surgery |
| US8795332B2 (en) * | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
| US5342376A (en) * | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
| US6241747B1 (en) * | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
| US5500000A (en) | 1993-07-01 | 1996-03-19 | United States Surgical Corporation | Soft tissue repair system and method |
| CA2133686C (en) | 1993-10-08 | 2006-10-03 | Elliott A. Gruskin | Infection-resistant surgical devices and methods of making them |
| AU690303B2 (en) * | 1994-06-28 | 1998-04-23 | Closure Medical Corporation | Ph-modified biocompatible monomer and polymer compositions |
| US5582616A (en) * | 1994-08-05 | 1996-12-10 | Origin Medsystems, Inc. | Surgical helical fastener with applicator |
| US5772640A (en) * | 1996-01-05 | 1998-06-30 | The Trustees Of Columbia University Of The City Of New York | Triclosan-containing medical devices |
| ES2144264T3 (es) | 1995-08-29 | 2000-06-01 | Exxon Chemical Patents Inc | Polipropileno tolerante a la radiacion y sus articulos utiles. |
| US5667528A (en) * | 1995-11-22 | 1997-09-16 | United States Surgical Corporation | Braided suture surgical incision member attachment |
| US6063105A (en) * | 1996-06-18 | 2000-05-16 | United States Surgical | Medical devices fabricated from elastomeric alpha-olefins |
| US5716376A (en) | 1996-06-28 | 1998-02-10 | United States Surgical Corporation | Absorbable mixture and coatings for surgical articles fabricated therefrom |
| DE19628909C2 (de) * | 1996-07-18 | 1999-11-18 | Ruesch Willy Ag | Verschluß |
| US5683417A (en) * | 1996-08-14 | 1997-11-04 | Cooper; William I. | Suture and method for endoscopic surgery |
| US5968077A (en) * | 1997-04-04 | 1999-10-19 | Alto Development Corporation | Double wire sternothomy suture |
| US5830234A (en) * | 1997-04-04 | 1998-11-03 | Alto Development Corporation | Method for double wire sternotomy suture |
| US5931855A (en) | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
| US6692499B2 (en) * | 1997-07-02 | 2004-02-17 | Linvatec Biomaterials Oy | Surgical fastener for tissue treatment |
| US6286746B1 (en) * | 1997-08-28 | 2001-09-11 | Axya Medical, Inc. | Fused loop of filamentous material and apparatus for making same |
| US20070021780A1 (en) * | 1997-08-28 | 2007-01-25 | Francis Harrington | Multicomponent fused suture loop and apparatus for making same |
| US6217591B1 (en) * | 1997-08-28 | 2001-04-17 | Axya Medical, Inc. | Suture fastening device |
| US5893880A (en) * | 1997-08-28 | 1999-04-13 | Axya Medical Inc. | Fused loop filamentous material |
| US6203564B1 (en) * | 1998-02-26 | 2001-03-20 | United States Surgical | Braided polyester suture and implantable medical device |
| US6613059B2 (en) * | 1999-03-01 | 2003-09-02 | Coalescent Surgical, Inc. | Tissue connector apparatus and methods |
| US6165202A (en) * | 1998-07-06 | 2000-12-26 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
| US6174324B1 (en) * | 1998-07-13 | 2001-01-16 | Axya Medical, Inc. | Suture guide and fastener |
| US6318575B1 (en) * | 1998-09-24 | 2001-11-20 | Dart Industries Inc. | Nesting insulated egg server |
| US6235869B1 (en) * | 1998-10-20 | 2001-05-22 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
| US6488690B1 (en) * | 1999-03-17 | 2002-12-03 | John K. Morris | Suture knot sealing instruments and methods of using the same |
| US6224579B1 (en) | 1999-03-31 | 2001-05-01 | The Trustees Of Columbia University In The City Of New York | Triclosan and silver compound containing medical devices |
| US6991643B2 (en) * | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
| US6926730B1 (en) * | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
| US7887551B2 (en) * | 1999-12-02 | 2011-02-15 | Smith & Nephew, Inc. | Soft tissue attachment and repair |
| JP2001198131A (ja) | 2000-01-18 | 2001-07-24 | Matsuda Ika Kk | 輪をもつ手術用縫合糸 |
| US6296659B1 (en) * | 2000-02-29 | 2001-10-02 | Opus Medical, Inc. | Single-tailed suturing method and apparatus |
| US20040010275A1 (en) * | 2000-05-19 | 2004-01-15 | Daniel Jacobs | Multi-point tissue tension distribution device and method, a custom-fittable variation |
| US6620846B1 (en) * | 2000-08-02 | 2003-09-16 | Closure Medical Corporation | Absorbable adhesive compositions |
| AU2001282982B2 (en) * | 2000-08-17 | 2007-01-04 | Covidien Lp | Sutures and coatings made from therapeutic absorbable glass |
| US6923824B2 (en) * | 2000-09-12 | 2005-08-02 | Axya Medical, Inc. | Apparatus and method for securing suture to bone |
| US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
| US6506197B1 (en) * | 2000-11-15 | 2003-01-14 | Ethicon, Inc. | Surgical method for affixing a valve to a heart using a looped suture combination |
| WO2002076521A2 (en) * | 2001-03-26 | 2002-10-03 | Tyco Healthcare Group Lp | Polyolefin sutures having improved processing and handling characteristics |
| US6599310B2 (en) | 2001-06-29 | 2003-07-29 | Quill Medical, Inc. | Suture method |
| US7056331B2 (en) * | 2001-06-29 | 2006-06-06 | Quill Medical, Inc. | Suture method |
| US6848152B2 (en) * | 2001-08-31 | 2005-02-01 | Quill Medical, Inc. | Method of forming barbs on a suture and apparatus for performing same |
| US20030097148A1 (en) * | 2001-11-20 | 2003-05-22 | Tero Valimaa | Tissue fastener |
| US20030149447A1 (en) * | 2002-02-01 | 2003-08-07 | Morency Steven David | Barbed surgical suture |
| US6773450B2 (en) * | 2002-08-09 | 2004-08-10 | Quill Medical, Inc. | Suture anchor and method |
| US20040087974A1 (en) * | 2002-09-16 | 2004-05-06 | Bittar Edward S. | Suture welding device and method of welding |
| US8100940B2 (en) * | 2002-09-30 | 2012-01-24 | Quill Medical, Inc. | Barb configurations for barbed sutures |
| US20040088003A1 (en) * | 2002-09-30 | 2004-05-06 | Leung Jeffrey C. | Barbed suture in combination with surgical needle |
| DE10254215B4 (de) | 2002-11-20 | 2014-10-09 | Johnson & Johnson Medical Gmbh | Chirurgisches Implantat |
| EP1569562A4 (en) * | 2002-12-13 | 2010-11-03 | Tyco Healthcare | ANTIMICROBIAL FATTY ACID CONTAINING SEAM COVER |
| US20040122451A1 (en) * | 2002-12-23 | 2004-06-24 | Wood Timothy J. | Method and device for closing and fusing suture loops |
| WO2004066927A2 (en) | 2003-01-24 | 2004-08-12 | Tyco Healthcare Group Lp | Bioabsorbable composition and coatings including same |
| WO2005080495A1 (en) | 2004-02-12 | 2005-09-01 | Exxonmobil Chemical Patents Inc. | Plasticized polyolefin compositions |
| WO2005087113A1 (en) * | 2004-03-08 | 2005-09-22 | Boston Scientific Limited | Fused suture knot |
| WO2005096955A1 (en) * | 2004-04-07 | 2005-10-20 | Tze Liang Woffles Wu | Surgical thread |
| US8236027B2 (en) * | 2004-04-07 | 2012-08-07 | Tze Liang Woffles Wu | Surgical thread |
| US20050267520A1 (en) | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
| DE102004047974A1 (de) * | 2004-10-01 | 2006-04-06 | Ethicon Gmbh | Chirurgischer Haken |
| CA2526541C (en) | 2004-12-01 | 2013-09-03 | Tyco Healthcare Group Lp | Novel biomaterial drug delivery and surface modification compositions |
| DE102005004318A1 (de) | 2005-01-31 | 2006-08-10 | Ethicon Gmbh | Chirurgisches Nahtsystem |
| US7736331B2 (en) * | 2005-03-11 | 2010-06-15 | Merit Medical Systems, Inc. | Drainage catheter hub with welded suture and sidewall stylet |
| US7632313B2 (en) * | 2005-04-29 | 2009-12-15 | Jmea Corporation | Disc repair system |
| US8663277B2 (en) * | 2005-06-29 | 2014-03-04 | Ethicon, Inc. | Braided barbed suture |
| US8491631B2 (en) * | 2006-01-30 | 2013-07-23 | Children's Medical Center Corporation | Tissue tack |
| US20080077181A1 (en) * | 2006-07-28 | 2008-03-27 | Angiotech Pharmaceuticals, Inc. | Minimally-invasive mastoplasty procedure using multiple barbed sutures and apparatus |
| ES2329092T3 (es) * | 2006-09-06 | 2009-11-20 | Tyco Healthcare Group, Lp | Suturas de puas. |
| WO2008042909A2 (en) | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
| ATE468827T1 (de) | 2007-03-07 | 2010-06-15 | Assut Europ S P A | Prothese zur behandlung der harninkontinenz |
| US20090099597A1 (en) * | 2007-10-12 | 2009-04-16 | Isse Nicanor G | Suture assembly with tissue engaging elements |
| US9034011B2 (en) * | 2008-04-01 | 2015-05-19 | Covidien Lp | Anchoring device |
| US10376261B2 (en) | 2008-04-01 | 2019-08-13 | Covidien Lp | Anchoring suture |
| US8961560B2 (en) * | 2008-05-16 | 2015-02-24 | Ethicon, Inc. | Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods |
| MX381532B (es) * | 2008-11-03 | 2025-03-12 | Ethicon Llc | Longitud de sutura autorretenible y metodo y dispositivo para su uso. |
-
2009
- 2009-01-29 US US12/362,002 patent/US10376261B2/en active Active
- 2009-02-25 AU AU2009200741A patent/AU2009200741B2/en not_active Ceased
- 2009-02-26 CA CA002655779A patent/CA2655779A1/en not_active Abandoned
- 2009-03-11 JP JP2009058588A patent/JP5570045B2/ja not_active Expired - Fee Related
- 2009-03-17 CA CA002658735A patent/CA2658735A1/en not_active Abandoned
- 2009-03-27 JP JP2009079732A patent/JP5570046B2/ja not_active Expired - Fee Related
- 2009-04-01 EP EP09251034.6A patent/EP2106752B1/en not_active Ceased
- 2009-04-01 EP EP09251035A patent/EP2106753B1/en not_active Ceased
- 2009-04-01 EP EP12166183.9A patent/EP2486857B1/en not_active Ceased
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4950285A (en) * | 1989-11-27 | 1990-08-21 | Wilk Peter J | Suture device |
| JPH04307052A (ja) * | 1991-01-07 | 1992-10-29 | United States Surgical Corp | ループ状糸付き外科用針−縫合糸組み合わせ装置 |
| JPH11502432A (ja) * | 1995-01-25 | 1999-03-02 | ユーン,インバエ | 組織の縫合方法および縫合装置 |
| JP2002511300A (ja) * | 1998-04-16 | 2002-04-16 | アクシーア メディカル インコーポレイテッド | 軟組織固定デバイス |
| JP2003512863A (ja) * | 1999-04-09 | 2003-04-08 | ジョゼフ カブコバ、ジョサファット | 組織の縫合方法及び装置 |
| JP2002224485A (ja) * | 2001-02-01 | 2002-08-13 | Bankoku Needle Mfg Co Ltd | ル−プ糸付き針 |
| US20060116718A1 (en) * | 2003-08-07 | 2006-06-01 | Leiboff Arnold R | Device and method for tacking a prosthetic screen |
| US20050267531A1 (en) * | 2004-05-14 | 2005-12-01 | Ruff Gregory L | Suture methods and devices |
| JP2007537017A (ja) * | 2004-05-14 | 2007-12-20 | クイル メディカル、インコーポレイテッド | 縫合方法および装置 |
| US20070224237A1 (en) * | 2006-03-24 | 2007-09-27 | Julia Hwang | Barbed sutures having a therapeutic agent thereon |
| WO2007133103A1 (en) * | 2006-05-16 | 2007-11-22 | Marlen Andreevich Sulamanidze | Surgical suture material and a method to the use thereof |
| US20080281357A1 (en) * | 2007-05-09 | 2008-11-13 | An-Min Jason Sung | Looped tissue-grasping device |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9498893B2 (en) | 2007-09-27 | 2016-11-22 | Ethicon, Inc. | Self-retaining sutures including tissue retainers having improved strength |
| JP2011019902A (ja) * | 2009-07-17 | 2011-02-03 | Tyco Healthcare Group Lp | 医療デバイスをコーティングする方法 |
| JP2011189131A (ja) * | 2010-03-12 | 2011-09-29 | Tyco Healthcare Group Lp | 外科手術用縫合糸のための展開システム |
| JP2011194234A (ja) * | 2010-03-19 | 2011-10-06 | Tyco Healthcare Group Lp | 先端がテーパー状にされたループ付き縫合糸 |
| JP2011240133A (ja) * | 2010-05-20 | 2011-12-01 | Tyco Healthcare Group Lp | 繋留デバイス |
| JP2013511322A (ja) * | 2010-06-09 | 2013-04-04 | メタ バイオメド カンパニー リミテッド | 手術用縫合糸の製造方法 |
| JP2013531533A (ja) * | 2010-07-08 | 2013-08-08 | アシュット ヨーロップ エス.ピー.エー. | 縫合糸 |
| JP2014516605A (ja) * | 2011-03-23 | 2014-07-17 | エシコン・エルエルシー | 自己保持可変ループ縫合材 |
| WO2013168932A1 (ko) * | 2012-05-07 | 2013-11-14 | Jeong Chang Wook | 결찰 장치 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2106753B1 (en) | 2013-03-13 |
| EP2106752A1 (en) | 2009-10-07 |
| EP2106752B1 (en) | 2014-06-11 |
| JP2009247890A (ja) | 2009-10-29 |
| EP2106753A1 (en) | 2009-10-07 |
| US10376261B2 (en) | 2019-08-13 |
| AU2009200741B2 (en) | 2014-09-18 |
| JP5570045B2 (ja) | 2014-08-13 |
| US20090248070A1 (en) | 2009-10-01 |
| JP5570046B2 (ja) | 2014-08-13 |
| CA2655779A1 (en) | 2009-10-01 |
| AU2009201099A1 (en) | 2009-10-15 |
| EP2486857A1 (en) | 2012-08-15 |
| CA2658735A1 (en) | 2009-10-01 |
| EP2486857B1 (en) | 2013-10-23 |
| AU2009200741A1 (en) | 2009-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5570045B2 (ja) | 繋留縫合糸 | |
| US8932327B2 (en) | Anchoring device | |
| JP5562546B2 (ja) | フィラメント補強されたコンポジットファイバー | |
| JP5656363B2 (ja) | 手術縫合糸配置システム | |
| JP6396402B2 (ja) | 自己保持可変ループ縫合材 | |
| KR101851119B1 (ko) | 자가-유지형 봉합재를 위한 표면 텍스처 구성 및 이를 형성하기 위한 방법 | |
| JP2011240133A (ja) | 繋留デバイス |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120207 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130121 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130515 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130520 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130819 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130822 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130919 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130925 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131018 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131023 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131120 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140127 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140618 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140623 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5570045 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |